Skip to main content
Clinical Trials/NL-OMON50802
NL-OMON50802
Not yet recruiting
Phase 4

Efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant bipolar depression. A multicenter, randomized, double-blind, sham-controlled study - T-Bide

Amsterdam UMC0 sites166 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
bipolar depression
Sponsor
Amsterdam UMC
Enrollment
166
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Amsterdam UMC

Eligibility Criteria

Inclusion Criteria

  • Eligibility criteria:
  • \- 18 years or older of age;
  • \- Sufficient level of spoken and written Dutch;
  • \- Ability to freely provide written informed consent;
  • \- patients with bipolar I or Il disorder, who have a medication\-resistant
  • bipolar depression, i.e., lack of remission for eight consecutive weeks after
  • two different adequate medication trials with at least two recommended
  • monotherapy treatments or at least one monotherapy treatment and another
  • combination
  • \- A score \> 16 points on the Hamilton depression rating scale for atypical

Exclusion Criteria

  • Partcipants meeting any of the following criteria will be excluded from
  • participation in this study:
  • \- A (hypo)manic episode within 3 months before the start of the trial.
  • \- A Young Mania Rating Scale score \> 12, before the start of the trial.
  • \- Current psychotic disorder, including psychotic depression, assessed at the
  • baseline interview.
  • \- Dementia, assessed with a dementia screening tool, i.e. the Montreal
  • Cognitive Assessment (34\), assessed at the baseline interview.
  • \- Active suicidal thoughts and intent to act on it, assessed at the baseline
  • interview and before the start of the trial. This assessment is based on the

Outcomes

Primary Outcomes

Not specified

Similar Trials